title: Pentobarbital withdrawal and treatment in an infant in the pediatric cardiac intensive care unit.
abstract: Withdrawal syndromes following administration of sedative and analgesic infusions represent a significant morbidity that is described increasingly in the pediatric critical care literature. However, there are few descriptions of pentobarbital withdrawal symptoms and their treatment in the pediatric population. We describe an infant receiving multiple sedative and analgesic medications, including pentobarbital, who was resistant to our institution's standard weaning protocol, but whose severe withdrawal symptoms responded dramatically to phenobarbital loading and maintenance.
authors.affiliation: Department of Anesthesiology, College of Physicians & Surgeons/Columbia University Medical Center, New York, NY 10032, USA. gmw9001@nyp.org
authors.forename: Garret M
authors.initials: GM
authors.lastname: Weber
authors.forename: Arthur J
authors.initials: AJ
authors.lastname: Smerling
authors.forename: John M
authors.initials: JM
authors.lastname: Saroyan
mesh_terms: D003422:Critical Care / Q000379:methods; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D007223:Infant; D015278:Intensive Care Units, Pediatric; D008297:Male; D010424:Pentobarbital / Q000009:adverse effects*; D010634:Phenobarbital / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
chemical_list: D006993:Hypnotics and Sedatives; D010424:Pentobarbital; D010634:Phenobarbital